Skip to content

Immediate Effect of Dry Needling on Trigger Points

Immediate Effect of Dry Needling on the Viscoelastic Properties of a Trigger Point on the Infraspinatus Muscle Measured With the MyotonPro

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04476381
Enrollment
48
Registered
2020-07-20
Start date
2018-02-01
Completion date
2019-09-20
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Pain

Keywords

myofascial trigger points,, dry needling,, stiffness

Brief summary

The immediate effects (0-30 minutes) of a dry needling intervention on a trigger point on their viscoelastic properties (tone, elasticity and stiffness)

Detailed description

Objectives: To investigate the immediate effects of a dry needling puncture on the viscoelastic properties (tone, stiffness and elasticity) of a trigger point (TP) located in the infraspinatus muscle in participants with non-traumatic chronic shoulder pain. Methods: Forty-eight individuals who presented non-traumatic chronic shoulder pain were recruited. The presence of a TP in the infraspinatus muscle of the painful side was confirmed by an experienced physiotherapist with a palpatory exam according to Travell and Simons criteria. The TP was marked and the viscoelastic properties including tone, stiffness and elasticity were measured with the MyotonPro device by an evaluator. After the first set of measurements (T1), an experienced physiotherapist applied a dry needling puncture to the TP with a pistoning technique to obtain a local twitch response (LTR) with an Optimed 40 x 0.30 mm single use acupuncture needle. The same set of measurements was repeated immediately after the dry needling (T2) and 30 minutes later (T3). Repeated measures ANOVA and post-hoc tests were used to assess changes in viscoelastic properties over time with a significant level set at 0.05.

Interventions

PROCEDUREDry needling

Insertion of a Optimed 40mm x 0.30 single use, sterile acupuncture needle into a active trigger point in the infraspinatus muscle

Sponsors

Université de Sherbrooke
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

One group, one measurement of the viscoelastic properties with the MyotonPro of a single trigger point before the dry needle insertion, one measurement with the MyotonPro right after and 30 minutes later

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. present with chronic shoulder pain of non-traumatic origin (rated at least 2/10 on a numeric rating scale (NRS) for more than 3 months. The pain had to be located in the shoulder area or referred in the area of the infraspinatus as described by Travell and Simons (1999); 2. have a hyperirritable spot within a palpable tight band that reproduced the participant's pain when compressed by palpation; and 3. have a body mass index (BMI) lower than 28

Exclusion criteria

1. diagnosis of capsulitis, cancer, or metastasis; 2. previous shoulder or thorax surgery or a mastectomy; 3. shoulder girdle bone fracture; 4. C4-C5 or C6 radiculopathy; 5. known osteoporotic profile (positive bone densitometry); 6. apparent atrophy of the infraspinatus fossa (visual interpretation) and 7. contraindications to receive a DN intervention

Design outcomes

Primary

MeasureTime frameDescription
Tone in Hertz measured with a myotonometer on the trigger pointbaselineMeasurement of the tone in Hz with the myotonometer MyotonPro on the trigger point
Stiffness in N/m with a myotonometer on the trigger pointbaselineMeasurement of the stiffness in N/m with the myotonometer MyotonPro on the trigger point
Elasticity (no units: inversely proportional to the decrement of the oscillations) with a myotonometer on the trigger pointbaselineMeasurement of the elasticity with the MyotonPro

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026